BACE2
BACE2 (beta-secretase 2, also known as ASP1, DRAP, ALP56, CEAP1 and AEPLC) is an integral membrane aspartic protease of the peptidase A1 family. It processes amyloid precursor protein, PMEL and CLTRN. Browse Assay Genie's current range of BACE2 research reagents below, or read on for the biology behind the target.
BACE2 is an aspartic protease responsible for the proteolytic processing of the amyloid precursor protein (APP). It cleaves APP between residues 690 and 691, which generates extracellular beta-cleaved soluble APP and a cell-associated C-terminal fragment that gamma-secretase later releases. It has also been shown to cleave APP between residues 671 and 672. The NCBI Gene summary notes that this cleavage yields amyloid beta peptide, a critical step in the aetiology of Alzheimer's disease and Down syndrome.
Beyond APP, BACE2 acts on other substrates. It is involved in the proteolytic shedding of PMEL at early stages of melanosome biogenesis, cleaving within the M-beta fragment to release the amyloidogenic PMEL luminal fragment containing M-alpha and a small portion of the M-beta N-terminus. This is a prerequisite for the subsequent processing and assembly of PMEL fibrils into amyloid sheets. BACE2 is also responsible for the proteolytic processing of CLTRN in pancreatic beta cells.
The BACE2 gene encodes an integral membrane glycoprotein that belongs to the peptidase A1 family. The precursor is further processed into an active mature peptide, and alternative splicing produces multiple transcript variants. UniProt places the protein at the cell membrane, Golgi apparatus, endoplasmic reticulum, endosome and melanosome. The previous name, beta-site APP-cleaving enzyme 2, reflects its relationship to BACE1, the other beta-secretase, and mouse and rat each have a Bace2 ortholog.
BACE2 cleaves APP in the step that generates amyloid beta peptide, which is critical in the aetiology of Alzheimer's disease.
The NCBI Gene summary links BACE2-mediated APP cleavage to amyloid beta production in the aetiology of Down syndrome.
BACE2 sheds PMEL early in melanosome biogenesis, a prerequisite for assembling PMEL fibrils into amyloid sheets.
BACE2 is responsible for the proteolytic processing of CLTRN in pancreatic beta cells, making it a protease of interest there.
BACE2 is an aspartic protease that cleaves amyloid precursor protein, releasing beta-cleaved soluble APP and leaving a C-terminal fragment for gamma-secretase. It also cleaves PMEL during melanosome biogenesis and processes CLTRN in pancreatic beta cells.
BACE2 stands for beta-secretase 2 and was previously named beta-site APP-cleaving enzyme 2. Aliases include ASP1, DRAP, ALP56, CEAP1 and AEPLC. Alternative splicing of the gene gives multiple transcript variants, and the precursor is processed into an active mature peptide.
Mouse and rat both have a Bace2 ortholog; check the datasheet of any product for its validated reactivity. BACE2 cleaves APP into amyloid beta peptide, a step described as critical in the aetiology of Alzheimer's disease and Down syndrome.
BACE1, the other beta-secretase, is a closely related target with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q9Y5Z0; product specifications from Assay Genie datasheets.